Astera Labs (NASDAQ:ALAB) COO Sells $30,845,920.50 in Stock

Key Points

• Astera Labs COO Sanjay Gajendra sold 90,630 shares at an average price of $340.35, totaling $30.85 million. The sale covered tax-withholding obligations tied to vested equity awards and reduced his direct holdings by 7.49% to 1.12 million shares.
• Astera Labs shares recently traded at $289.02, with a market capitalization of about $50.14 billion and a 52-week range of $97.89 to $499.48. The stock’s consensus analyst rating is Moderate Buy, with an average price target of $333.
• The company exceeded quarterly expectations, reporting $0.80 in EPS versus $0.69 expected and revenue of $392.4 million versus $360.85 million expected. Revenue increased 104.5% year over year, while institutional investors own 60.47% of the shares.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares of the company's stock, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Sanjay Gajendra also recently made the following trade(s):

• On Thursday, May 21st, Sanjay Gajendra sold 400,000 shares of Astera Labs stock. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00.

Astera Labs Stock Performance

Shares of Astera Labs stock traded down $14.42 on Wednesday, reaching $289.02. The company had a trading volume of 4,217,656 shares, compared to its average volume of 5,487,682. The firm's 50 day moving average price is $356.72 and its two-hundred day moving average price is $242.75. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The firm has a market cap of $50.14 billion, a PE ratio of 143.08 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts' consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analysts' expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm's quarterly revenue was up 104.5% on a year-over-year basis. During the same quarter last year, the company posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, sell-side analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current year.

Institutional Investors Weigh In On Astera Labs

A number of hedge funds have recently bought and sold shares of the stock. Eurizon Capital SGR S.p.A. purchased a new stake in shares of Astera Labs in the 4th quarter valued at about $18,708,000. Swedbank AB grew its stake in Astera Labs by 76.8% during the 4th quarter. Swedbank AB now owns 78,140 shares of the company's stock worth $12,999,000 after buying an additional 33,940 shares during the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new position in Astera Labs during the 4th quarter worth approximately $499,000. Revere Asset Management Inc acquired a new position in Astera Labs during the fourth quarter worth approximately $589,000. Finally, Mitsubishi UFJ Trust & Banking Corp purchased a new stake in Astera Labs in the fourth quarter valued at approximately $10,299,000. Institutional investors and hedge funds own 60.47% of the company's stock.

Analysts Set New Price Targets

Several research firms have weighed in on ALAB. Stifel Nicolaus lifted their target price on Astera Labs from $260.00 to $460.00 and gave the company a "buy" rating in a research report on Wednesday, June 24th. Northland Securities upgraded shares of Astera Labs from a "market perform" rating to an "outperform" rating and set a $350.00 price objective for the company in a report on Monday. Zacks Research raised shares of Astera Labs from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, August 11th. Royal Bank Of Canada increased their target price on shares of Astera Labs from $425.00 to $500.00 and gave the stock an "outperform" rating in a report on Wednesday, August 5th. Finally, Evercore reissued an "outperform" rating and issued a $297.00 price target on shares of Astera Labs in a research report on Tuesday, May 19th. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $333.00.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source